56
Views
0
CrossRef citations to date
0
Altmetric
Special Section: Selected Articles from the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2020 - Lead and Impact: Turning Innovation into Practice

Backward Sequential Significance Testing in Survival Trials

Pages 505-510 | Received 20 Nov 2020, Accepted 25 Jul 2022, Published online: 03 Oct 2022
 

Abstract

In survival studies the treatment effect on the hazard ratio may not extend over the entire observation time, yet the effect over a shorter time may be medically important. If the analysis using all events over the observation time does not show a significant benefit, then post hoc analyses at earlier times, which show nominal significance, would only be viewed as post hoc and suggestive of an effect. Therefore, it would be advantageous to incorporate a shorter duration of treatment effect into the study design. A backward sequential logrank procedure, with testing at the end of study and if not significant then sequentially at prespecified earlier time points with a prespecified distribution of Type I error, is proposed. Critical values and power are obtained by simulation for repeated logrank tests at prespecified times and α distribution. When the treatment effect does not extend over the entire observation period the backward logrank testing procedure is more powerful compared to the power of a single logrank test at the end of the study.

Disclosure Statement

The author reports there are no competing interests to declare

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.